Filing Details
- Accession Number:
- 0001012975-13-000439
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-16 17:48:59
- Reporting Period:
- 2013-09-12
- Filing Date:
- 2013-09-16
- Accepted Time:
- 2013-09-16 17:48:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100412 | Array Biopharma Inc | ARRY | Pharmaceutical Preparations (2834) | 841460811 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1547100 | Liam Ratcliffe | C/O New Leaf Venture Partners 7 Times Square, Suite 3502 New York NY 10036 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-09-12 | 807,479 | $6.10 | 1,991,421 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2013-09-13 | 546,660 | $6.01 | 1,444,761 | No | 4 | S | Indirect | See footnote |
Common Stock | Disposition | 2013-09-16 | 319,033 | $6.14 | 1,125,728 | No | 4 | S | Indirect | See footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
No | 4 | S | Indirect | See footnote |
Footnotes
- Represents shares owned directly by New Leaf Ventures II, L.P., a limited partnership of which the sole general partner is New Leaf Venture Associates II, L.P. ("NLVA II"). Dr. Liam Ratcliffe ("Dr. Ratcliffe"), in his capacity as a limited partner of NLVA II, may be deemed to beneficially own the shares to which this Form 4 relates. Dr. Ratcliffe disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.